Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis—A Multicenter European Prospective Cohort Study (EPIC)

Background: Oxidative stress may be involved in the aetiology of inflammatory bowel disease and whether dietary polyphenols, which possess antioxidants properties, prevent its development is unknown. Methods: A total of 401,326 men and women aged 20 to 80 years from 8 countries were recruited between 1991 and 1998 and at baseline completed validated food frequency questionnaires. Dietary polyphenol intake was measured using Phenol-Explorer, a database with information on the content of 502 polyphenols. Incident cases of Crohn's diseases (CD) and ulcerative colitis (UC) were identified during the follow-up period of up to December 2010. A nested case–control study using conditional logistic regression estimated the odds ratios (ORs), and 95% confidence intervals, for polyphenol intake (categories based on quartiles) and developing CD or UC. Results: In total, 110 CD (73% women) and 244 UC (57% women) cases were identified and matched to 440 and 976 controls, respectively. Total polyphenol intake was not associated with CD (P trend = 0.17) or UC (P trend = 0.16). For flavones and CD, there were reduced odds for all quartiles, which were statistically significant for the third (OR3rd versus 1st quartile = 0.33; 95% confidence interval, 0.15–0.69) and there was an inverse trend across quartiles (P = 0.03). Similarly, for resveratrol, there was an inverse association with CD (OR4th versus 1st quartile = 0.40; 95% confidence interval, 0.20–0.82) with an inverse trend across quartiles (P = 0.02). No significant associations between subtypes of polyphenols and UC were found. Effect modification by smoking in CD was documented with borderline statistical significance. Conclusions: The data supports a potential role of flavones and resveratrol in the risk of developing CD; future aetiological studies should investigate these dietary components and further examine the potential for residual confounding.

[1]  E. Riboli,et al.  Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study , 2016, European Journal of Nutrition.

[2]  J. Teixeira,et al.  Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[3]  Dongfeng Zhang,et al.  Dietary fiber intake reduces risk of inflammatory bowel disease: result from a meta-analysis. , 2015, Nutrition research.

[4]  F. Milagro,et al.  Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. , 2015, The Journal of nutritional biochemistry.

[5]  V. Apostolopoulos,et al.  NADPH oxidases and inflammatory bowel disease. , 2015, Current medicinal chemistry.

[6]  S. Hutfless,et al.  Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis. , 2014, Journal of Crohn's & colitis.

[7]  J. Fichna,et al.  Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  R. Rocha,et al.  Restriction of dairy products; a reality in inflammatory bowel disease patients. , 2014, Nutricion hospitalaria.

[9]  E. Riboli,et al.  Association between high dietary intake of the n−3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease , 2014, Alimentary pharmacology & therapeutics.

[10]  W. Willett,et al.  A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. , 2013, Gastroenterology.

[11]  L. Kovács,et al.  Effect of natural polyphenols (Pycnogenol) on oxidative stress markers in children suffering from Crohn's disease – a pilot study , 2013, Free radical research.

[12]  D. Quilliot,et al.  Dietary Beliefs and Behavior Among Inflammatory Bowel Disease Patients , 2013, Inflammatory bowel diseases.

[13]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[14]  M. A. Rosillo,et al.  Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. , 2011, Biochemical pharmacology.

[15]  L. Ferguson,et al.  Effects of dairy products on crohn's disease symptoms are influenced by fat content and disease location but not lactose content or disease activity status in a New Zealand population. , 2011, Journal of the American Dietetic Association.

[16]  A. Scalbert,et al.  The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. , 2011, The Journal of nutrition.

[17]  H. El‐Serag,et al.  Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature , 2011, The American Journal of Gastroenterology.

[18]  J. Bassaganya-Riera,et al.  Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease , 2010, Current opinion in clinical nutrition and metabolic care.

[19]  J. O'connor,et al.  Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease , 2010, Inflammatory bowel diseases.

[20]  E. Riboli,et al.  Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case–control study within a European prospective cohort study , 2009, Gut.

[21]  J. Lewis,et al.  Passive Smoking and Inflammatory Bowel Disease: A Meta-Analysis , 2008, The American Journal of Gastroenterology.

[22]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[23]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[24]  R. Sartor.  Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[25]  C. McClain,et al.  Polyphenols and gastrointestinal diseases , 2006, Current opinion in gastroenterology.

[26]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[27]  H. Verspaget,et al.  Oxidative stress as a pathogenic factor in inflammatory bowel disease — radicals or ridiculous? , 2002, Alimentary pharmacology & therapeutics.

[28]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[29]  G. Williamson,et al.  Dietary intake and bioavailability of polyphenols. , 2000, The Journal of nutrition.

[30]  J. Lennard-jones,et al.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). , 1996, Gut.

[31]  D. Rachmilewitz,et al.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. , 1995, Gut.